Annual Total Liabilities
$97.80 M
-$5.59 M-5.40%
December 31, 2023
Summary
- As of February 7, 2025, SLN annual total liabilities is $97.80 million, with the most recent change of -$5.59 million (-5.40%) on December 31, 2023.
- During the last 3 years, SLN annual total liabilities has fallen by -$7.02 million (-6.70%).
- SLN annual total liabilities is now -17.34% below its all-time high of $118.32 million, reached on December 31, 2021.
Performance
SLN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$100.19 M
+$3.90 M+4.05%
September 1, 2024
Summary
- As of February 7, 2025, SLN quarterly total liabilities is $100.19 million, with the most recent change of +$3.90 million (+4.05%) on September 1, 2024.
- Over the past year, SLN quarterly total liabilities has increased by +$2.39 million (+2.44%).
- SLN quarterly total liabilities is now -15.32% below its all-time high of $118.32 million, reached on December 31, 2021.
Performance
SLN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SLN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.4% | +2.4% |
| 3 y3 years | -6.7% | -3.1% |
| 5 y5 years | +1912.4% | -3.1% |
SLN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.3% | at low | -15.3% | +12.6% |
| 5 y | 5-year | -17.3% | +196.4% | -15.3% | +203.6% |
| alltime | all time | -17.3% | >+9999.0% | -15.3% | +7250.1% |
Silence Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $100.19 M(+4.1%) |
| Jun 2024 | - | $96.29 M(+8.2%) |
| Mar 2024 | - | $88.98 M(-9.0%) |
| Dec 2023 | $97.80 M(-5.4%) | $97.80 M(+2.8%) |
| Sep 2023 | - | $95.10 M(-6.3%) |
| Jun 2023 | - | $101.48 M(+5.4%) |
| Mar 2023 | - | $96.29 M(-6.9%) |
| Dec 2022 | $103.39 M(-12.6%) | $103.39 M(+3.0%) |
| Sep 2022 | - | $100.40 M(-6.1%) |
| Jun 2022 | - | $106.91 M(-1.7%) |
| Mar 2022 | - | $108.76 M(-8.1%) |
| Dec 2021 | $118.32 M(+12.9%) | $118.32 M(+15.3%) |
| Sep 2021 | - | $102.58 M(-3.8%) |
| Jun 2021 | - | $106.65 M(+1.7%) |
| Dec 2020 | $104.82 M(+217.6%) | $104.82 M(+17.5%) |
| Jun 2020 | - | $89.19 M(+170.3%) |
| Dec 2019 | $33.00 M(+579.0%) | - |
| Dec 2019 | - | $33.00 M(+810.8%) |
| Jun 2019 | - | $3.62 M(-25.4%) |
| Dec 2018 | $4.86 M(+35.3%) | - |
| Dec 2018 | - | $4.86 M(+3.2%) |
| Jun 2018 | - | $4.71 M(+31.2%) |
| Dec 2017 | $3.59 M(+81.5%) | - |
| Dec 2017 | - | $3.59 M(-0.3%) |
| Jun 2017 | - | $3.60 M(+82.1%) |
| Dec 2016 | $1.98 M(+19.4%) | - |
| Dec 2016 | - | $1.98 M(-3.3%) |
| Jun 2016 | - | $2.05 M(+23.5%) |
| Dec 2015 | $1.66 M(-47.1%) | - |
| Dec 2015 | - | $1.66 M(+13.7%) |
| Jun 2015 | - | $1.46 M(-53.5%) |
| Dec 2014 | $3.13 M(+10.2%) | - |
| Dec 2014 | - | $3.13 M(+20.5%) |
| Jun 2014 | - | $2.60 M(-8.5%) |
| Dec 2013 | $2.84 M(+83.4%) | - |
| Dec 2013 | - | $2.84 M(+100.2%) |
| Jun 2013 | - | $1.42 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $1.55 M(-20.2%) | - |
| Dec 2012 | - | $1.55 M(+1.8%) |
| Jun 2012 | - | $1.52 M(-21.6%) |
| Dec 2011 | $1.94 M(-25.4%) | - |
| Dec 2011 | - | $1.94 M(-41.7%) |
| Jun 2011 | - | $3.33 M(+28.0%) |
| Dec 2010 | $2.60 M(-23.5%) | - |
| Dec 2010 | - | $2.60 M(-36.7%) |
| Jun 2010 | - | $4.11 M(+20.8%) |
| Dec 2009 | $3.40 M(+148.3%) | - |
| Dec 2009 | - | $3.40 M(+149.5%) |
| Jun 2009 | - | $1.36 M(-0.5%) |
| Dec 2008 | $1.37 M(-61.7%) | - |
| Dec 2008 | - | $1.37 M(-12.6%) |
| Jun 2008 | - | $1.57 M(-56.2%) |
| Dec 2007 | $3.58 M(+75.0%) | - |
| Dec 2007 | - | $3.58 M(-7.6%) |
| Jun 2007 | - | $3.87 M(+89.4%) |
| Dec 2006 | $2.04 M(-19.9%) | - |
| Dec 2006 | - | $2.04 M(+22.9%) |
| Jun 2006 | - | $1.66 M(-34.9%) |
| Dec 2005 | $2.55 M(+57.3%) | - |
| Dec 2005 | - | $2.55 M(+51.3%) |
| Jun 2005 | - | $1.69 M(+4.0%) |
| Dec 2004 | $1.62 M(-30.5%) | - |
| Dec 2004 | - | $1.62 M(+8.9%) |
| Jun 2004 | - | $1.49 M(-36.2%) |
| Dec 2003 | $2.34 M(+40.9%) | - |
| Dec 2003 | - | $2.34 M(+23.5%) |
| Jun 2003 | - | $1.89 M |
| Dec 2002 | $1.66 M(+57.8%) | - |
| Dec 2001 | $1.05 M(-26.9%) | - |
| Dec 2000 | $1.44 M(-44.5%) | - |
| Dec 1999 | $2.59 M(+159.7%) | - |
| Dec 1998 | $997.30 K(-5.9%) | - |
| Dec 1997 | $1.06 M(+49.6%) | - |
| Dec 1996 | $708.70 K(+51.8%) | - |
| Dec 1995 | $466.90 K | - |
FAQ
- What is Silence Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Silence Therapeutics?
- What is Silence Therapeutics annual total liabilities year-on-year change?
- What is Silence Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Silence Therapeutics?
- What is Silence Therapeutics quarterly total liabilities year-on-year change?
What is Silence Therapeutics annual total liabilities?
The current annual total liabilities of SLN is $97.80 M
What is the all time high annual total liabilities for Silence Therapeutics?
Silence Therapeutics all-time high annual total liabilities is $118.32 M
What is Silence Therapeutics annual total liabilities year-on-year change?
Over the past year, SLN annual total liabilities has changed by -$5.59 M (-5.40%)
What is Silence Therapeutics quarterly total liabilities?
The current quarterly total liabilities of SLN is $100.19 M
What is the all time high quarterly total liabilities for Silence Therapeutics?
Silence Therapeutics all-time high quarterly total liabilities is $118.32 M
What is Silence Therapeutics quarterly total liabilities year-on-year change?
Over the past year, SLN quarterly total liabilities has changed by +$2.39 M (+2.44%)